Author:
Al-Batran S-E.,Haag G.M.,Ettrich T.J.,Borchert K.,Kretzschmar A.,Teschendorf C.,Siegler G.M.,Ebert M.,Goekkurt E.,Welslau M.K.,Mahlberg R.J.C.,Homann N.,Pink D.,Bechstein W.O.,Reichardt P.,Gaiser T.,Sookthai D.,Pauligk C.,Goetze T.O.,Hofheinz R.D.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HER2-Positive Gastric Cancer and Antibody Treatment: State of the Art and Future Developments;Cancers;2024-03-29
2. Medikamentöse Therapiestrategien des Magenkarzinoms;TumorDiagnostik & Therapie;2024-03-27
3. Advances in targeted therapy for gastric cancer based on tumor driver genes;Journal of Zhejiang University (Medical Sciences);2024-02-01
4. Esophageal cancer - French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR);Digestive and Liver Disease;2023-12
5. Updated Adjuvant Chemotherapy for Gastric Cancer;Journal of Clinical Medicine;2023-10-24